IBUPROFEN SODIUM Drug Patent Profile
✉ Email this page to a colleague
When do Ibuprofen Sodium patents expire, and what generic alternatives are available?
Ibuprofen Sodium is a drug marketed by Perrigo R And D and is included in one NDA.
The generic ingredient in IBUPROFEN SODIUM is ibuprofen sodium. There is one drug master file entry for this compound. One supplier is listed for this compound. Additional details are available on the ibuprofen sodium profile page.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for IBUPROFEN SODIUM?
- What are the global sales for IBUPROFEN SODIUM?
- What is Average Wholesale Price for IBUPROFEN SODIUM?
Summary for IBUPROFEN SODIUM
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 13 |
| Clinical Trials: | 50 |
| Patent Applications: | 50 |
| DailyMed Link: | IBUPROFEN SODIUM at DailyMed |
Recent Clinical Trials for IBUPROFEN SODIUM
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Armed Forces Post Graduate Medical Institute (AFPGMI), Rawalpindi | NA |
| Oman Medical Speciality Board | NA |
| Hospital for Special Surgery, New York | PHASE3 |
Anatomical Therapeutic Chemical (ATC) Classes for IBUPROFEN SODIUM
US Patents and Regulatory Information for IBUPROFEN SODIUM
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Perrigo R And D | IBUPROFEN SODIUM | ibuprofen sodium | TABLET;ORAL | 206581-001 | Aug 3, 2015 | DISCN | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
